tolvaptan has been researched along with Diabetes Mellitus in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Fujimori, K; Fushimi, K; Miyazaki, D; Tarasawa, K | 1 |
| Hada, T; Kawano, M; Muramatsu, T; Nakano, M; Nishio, S; Takimura, H; Takimura, Y; Tsukahara, R; Yabe, T | 1 |
| Achtari Jeanneret, L; Barras-Moret, AC; Carron, P; Deriaz-Chessex, S; Donzé, J; Fournier, Y; Gachoud, D; Moix, PA; Monti, M; Rossier, A; Wilson, P | 1 |
3 other study(ies) available for tolvaptan and Diabetes Mellitus
| Article | Year |
|---|---|
Risk factors of readmission and the impact of outpatient management in heart failure patients: A national study in Japan.
Topics: Diabetes Mellitus; Female; Heart Failure; Humans; Japan; Outpatients; Patient Readmission; Risk Factors; Sodium Potassium Chloride Symporter Inhibitors; Tolvaptan | 2023 |
A novel validated method for predicting the risk of re-hospitalization for worsening heart failure and the effectiveness of the diuretic upgrading therapy with tolvaptan.
Topics: Aged; Aged, 80 and over; Diabetes Mellitus; Diuretics; Female; Heart Failure; Heart Rate; Hematocrit; Hemoglobins; Hospitalization; Humans; Male; Risk Factors; Tolvaptan; Uric Acid | 2018 |
[Highlights 2007 in hospital-based internal medicine: the point of view from the chief residents].
Topics: Accidental Falls; Aged; Albuterol; Anemia; Anticoagulants; Antidiuretic Hormone Receptor Antagonists; Atrial Fibrillation; Attitude of Health Personnel; Benzazepines; Bronchitis, Chronic; Bronchodilator Agents; Cardiac Pacing, Artificial; Diabetes Mellitus; Endocarditis, Bacterial; Erythropoietin; Heart Failure; Heparin; Humans; Internal Medicine; Interprofessional Relations; Medical Staff, Hospital; Myocardial Infarction; Recombinant Proteins; Risk Management; Rosiglitazone; Salmeterol Xinafoate; Thiazolidinediones; Thromboembolism; Tolvaptan; Vasodilator Agents; Ventricular Dysfunction, Left; Workload | 2008 |